Axsome Therapeutics Inc. (0HKF)
LSE
Closed
Oct 8, 2026
Day's Range
166.2552 wk Range
117.94Overview - 0HKF - Axsome Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
10.19B
Price / Sales (TTM)
‪304.42‬
Price / Book
‪122.90‬
EV / EBITDA
‪-58.96‬
Profitability
Gross Margin
‪19.20%‬
Profit Margin
‪-24.67%‬
Operating Margin
‪-23.41%‬
Return on Assets
‪-16.31%‬
Return on Equity
‪-245.10%‬
Ownership
Shares Outstanding
29.81M
Float
44.46M
Held by Insiders
‪15.08%‬
Held by Institutions
‪74.59%‬
Price stats
Beta
‪0.70‬
50-Day Avg
‪85.35‬
200-Day Avg
‪75.30‬
Market Cap - 0HKF - Axsome Therapeutics Inc.
Peers - 0HKF - Axsome Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0HKFLSEAxsome Therapeutics Inc.5.83BMarket Cap+40.04%52-week change—P/E (Trailing)‪-24.67%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0HKF - Axsome Therapeutics Inc.
About
Axsome Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system disorders. Its marketed products include Auvelity for major depressive disorder, Sunosi for excessive daytime sleepiness related to narcolepsy or obstructive sleep apnea, and Symbravo…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
